PG
PFE icon

PEAK6 Group’s Pfizer PFE Stock Holding History

PEAK6 Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$10.3M Buy
299,863
+219,337
+272% +$7.5M 0.04% 434
2018
Q1 		$2.71M Sell
80,526
-4,321
-5% -$149K 0.01% 1172
2017
Q4 		$2.92M Sell
84,847
-963,672
-92% -$32.9M 0.01% 1140
2017
Q3 		$35.5M Buy
1,048,519
+581,702
+125% +$18.7M 0.18% 93
2017
Q2 		$14.9M Buy
466,817
+328,005
+236% +$10.3M 0.09% 245
2017
Q1 		$4.5M Sell
138,812
-17,496
-11% -$552K 0.04% 624
2016
Q4 		$4.82M Buy
156,308
+132,382
+553% +$4.04M 0.03% 731
2016
Q3 		$769K Sell
23,926
-109,089
-82% -$3.65M 0.01% 1997
2016
Q2 		$4.44M Buy
+133,015
New +$4.25M 0.03% 742
2016
Q1 		– Sell
-4,954
Closed -$152K – 4896
2015
Q4 		$152K Sell
4,954
-132,804
-96% -$4.18M ﹤0.01% 3668
2015
Q3 		$4.11M Sell
137,758
-296,912
-68% -$9.52M 0.02% 1036
2015
Q2 		$13.8M Sell
434,670
-115,307
-21% -$3.76M 0.08% 290
2015
Q1 		$18.2M Buy
549,977
+129,747
+31% +$4.12M 0.14% 145
2014
Q4 		$12.4M Sell
420,230
-75,677
-15% -$2.17M 0.09% 250
2014
Q3 		$13.9M Buy
495,907
+475,354
+2,313% +$13.3M 0.11% 217
2014
Q2 		$579K Sell
20,553
-35,414
-63% -$1.01M 0.01% 2179
2014
Q1 		$1.71M Buy
55,967
+29,617
+112% +$883K 0.01% 1398
2013
Q4 		$766K Sell
26,350
-111,724
-81% -$3.25M 0.01% 2283
2013
Q3 		$1.88M Buy
138,074
+106,032
+331% +$2.89M 0.01% 1585
2013
Q2 		$851 Buy
+32,042
New +$885K ﹤0.01% 2284

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Group's PFE Position: Q2 2018 in Review

PEAK6 Group sold out of Pfizer (PFE) in Q2 2018, closing a stake of 412,038 shares — an estimated $14.1M sold.

PEAK6 Group first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $13.9M in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • PEAK6 Group reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 412,038 Pfizer shares in Q2 2018, an estimated $14.1M.
  • PEAK6 Group first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Pfizer position peaked at $13.9M in Q1 2018.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.